These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11941562)

  • 1. Safety of Lactobacillus strains used as probiotic agents.
    Sipsas NV; Zonios DI; Kordossis T
    Clin Infect Dis; 2002 May; 34(9):1283-4; author reply 1284-5. PubMed ID: 11941562
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety of lactobacillus strains as probiotic agents.
    Reid G
    Clin Infect Dis; 2002 Aug; 35(3):349-50. PubMed ID: 12115112
    [No Abstract]   [Full Text] [Related]  

  • 3. Safety of probiotics: translocation and infection.
    Liong MT
    Nutr Rev; 2008 Apr; 66(4):192-202. PubMed ID: 18366533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety evaluation of Lactobacillus delbrueckii subsp. lactis UO 004, a probiotic bacterium.
    Fernández MF; Boris S; Barbés C
    Res Microbiol; 2005 Mar; 156(2):154-60. PubMed ID: 15748979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lactobacillus sepsis associated with probiotic therapy.
    Land MH; Rouster-Stevens K; Woods CR; Cannon ML; Cnota J; Shetty AK
    Pediatrics; 2005 Jan; 115(1):178-81. PubMed ID: 15629999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety assessment of Lactobacillus strains: presence of putative risk factors in faecal, blood and probiotic isolates.
    Vesterlund S; Vankerckhoven V; Saxelin M; Goossens H; Salminen S; Ouwehand AC
    Int J Food Microbiol; 2007 May; 116(3):325-31. PubMed ID: 17391794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of Lactobacillus GG probiotic in infants with very low birth weight: twelve years of experience.
    Luoto R; Isolauri E; Lehtonen L
    Clin Infect Dis; 2010 May; 50(9):1327-8. PubMed ID: 20367236
    [No Abstract]   [Full Text] [Related]  

  • 8. Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland.
    Salminen MK; Tynkkynen S; Rautelin H; Saxelin M; Vaara M; Ruutu P; Sarna S; Valtonen V; Järvinen A
    Clin Infect Dis; 2002 Nov; 35(10):1155-60. PubMed ID: 12410474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver abscess and bacteremia caused by lactobacillus: role of probiotics? Case report and review of the literature.
    Sherid M; Samo S; Sulaiman S; Husein H; Sifuentes H; Sridhar S
    BMC Gastroenterol; 2016 Nov; 16(1):138. PubMed ID: 27863462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral administration of two probiotic strains, Lactobacillus gasseri CECT5714 and Lactobacillus coryniformis CECT5711, enhances the intestinal function of healthy adults.
    Olivares M; Díaz-Ropero MA; Gómez N; Lara-Villoslada F; Sierra S; Maldonado JA; Martín R; López-Huertas E; Rodríguez JM; Xaus J
    Int J Food Microbiol; 2006 Mar; 107(2):104-11. PubMed ID: 16271414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of probiotics that contain lactobacilli or bifidobacteria.
    Borriello SP; Hammes WP; Holzapfel W; Marteau P; Schrezenmeir J; Vaara M; Valtonen V
    Clin Infect Dis; 2003 Mar; 36(6):775-80. PubMed ID: 12627362
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Pararajasingam A; Uwagwu J
    BMJ Case Rep; 2017 Sep; 2017():. PubMed ID: 28903972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety assessment of two probiotic strains, Lactobacillus coryniformis CECT5711 and Lactobacillus gasseri CECT5714.
    Lara-Villoslada F; Sierra S; Martín R; Delgado S; Rodríguez JM; Olivares M; Xaus J
    J Appl Microbiol; 2007 Jul; 103(1):175-84. PubMed ID: 17584463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subtractive screening for probiotic properties of lactobacillus species from the human gastrointestinal tract in the search for new probiotics.
    Delgado S; O'Sullivan E; Fitzgerald G; Mayo B
    J Food Sci; 2007 Oct; 72(8):M310-5. PubMed ID: 17995611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonistic activity of probiotic lactobacilli and bifidobacteria against entero- and uropathogens.
    Hütt P; Shchepetova J; Lõivukene K; Kullisaar T; Mikelsaar M
    J Appl Microbiol; 2006 Jun; 100(6):1324-32. PubMed ID: 16696680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of a multispecies probiotic mixture to prevent infectious complications in critically ill patients.
    Timmerman HM; Niers LE; Ridwan BU; Koning CJ; Mulder L; Akkermans LM; Rombouts FM; Rijkers GT
    Clin Nutr; 2007 Aug; 26(4):450-9. PubMed ID: 17544549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential risk of probiotic usage.
    Barrett JF
    Expert Opin Drug Saf; 2006 Jan; 5(1):3-4. PubMed ID: 16370949
    [No Abstract]   [Full Text] [Related]  

  • 18. Probiotic potential of 3 Lactobacilli strains isolated from breast milk.
    Martín R; Olivares M; Marín ML; Fernández L; Xaus J; Rodríguez JM
    J Hum Lact; 2005 Feb; 21(1):8-17; quiz 18-21, 41. PubMed ID: 15681631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of oral lactobacilli as potential probiotics for oral health.
    Kõll P; Mändar R; Marcotte H; Leibur E; Mikelsaar M; Hammarström L
    Oral Microbiol Immunol; 2008 Apr; 23(2):139-47. PubMed ID: 18279182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection of lactobacillus strains for urogenital probiotic applications.
    Reid G; Bruce AW
    J Infect Dis; 2001 Mar; 183 Suppl 1():S77-80. PubMed ID: 11171021
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.